Article
Application of Genome Editing Techniques in Immunology
17 Jan 2018
Abstract excerpt
The idea of using the effector immune cells to specifically fight cancer has recently evolved into an exciting concept of adoptive cell therapies. Indeed, genetically engineered T cells expressing on their surface recombinant, cancer-targeted receptors have been shown to induce promising response in oncological patients. However, in addition to exogenous expression of such receptors, there is also a need for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
